Ozempic and Mounjaro Are Melting Fat, But What Are They Doing to Your Muscles and Joints?
Quick Summary
Explores how Ozempic and Mounjaro, popular in Indian metros for weight loss, can cause meaningful muscle loss alongside fat loss, backed by Indian sarcopenia and real-world weight-loss data. Covers the two-sided joint story: weight loss eases knee osteoarthritis pain, but muscle loss can offset that benefit. Offers practical protection tips, protein, resistance training, and monitoring, alongside drug-free TENS/EMS and core-support devices as complementary aids. Overall a balanced, non-alarmist piece encouraging supervised, muscle-conscious use of these medications.
Why Ozempic and Mounjaro Are Everywhere Right Now
Ozempic and Mounjaro have become household names in Indian metro cities, promising kilos lost without crash diets or hours at the gym. But as more Indians turn to these injections for weight loss, doctors are raising a quieter concern: some of the weight coming off isn't fat at all, it's muscle. And muscle loss doesn't just change how you look. It can affect your strength, your balance, and the health of your knees and joints for years to come. Understanding this trade-off matters before you start, or continue, this treatment.
Ozempic (semaglutide) and Mounjaro (tirzepatide) belong to a class of drugs called GLP-1 receptor agonists, originally developed for type 2 diabetes and now widely used for Ozempic weight loss and Mounjaro weight loss. They work by slowing digestion and reducing appetite, which leads to significant calorie reduction.
Obesity in India is no small issue. According to the ICMR-INDIAB study, generalized obesity affects close to 29% of Indian adults, while abdominal obesity affects nearly 40%. Many Indians also carry higher body fat at a lower BMI than Western populations, a pattern researchers call normal weight obesity, which makes these drugs appealing even to people who don't look conventionally overweight.
A retrospective study from a Delhi hospital, one of the first on Indian patients, found real-world results were more modest than global trials. Patients on tirzepatide lost a median of 8.6% of body weight, compared with 5.6% for those on semaglutide, over roughly six months. Global trials of Ozempic have shown even higher numbers under supervised conditions, with a majority of participants losing more than 5% of body weight within a similar timeframe.
The Weight Comes Off, But So Does Muscle
This is where the story gets complicated. When you lose weight quickly, whether through dieting or medication, your body doesn't burn fat exclusively. A meaningful share of that weight loss comes from lean tissue, including skeletal muscle.
Research suggests that 20 to 40 percent of weight lost during dieting or medication assisted weight loss is lean muscle mass, with the rest being fat. In major obesity trials, participants using semaglutide or tirzepatide lost more than 10% of their muscle mass over roughly 68 to 72 weeks, an amount some experts compare to two decades of natural age-related muscle decline. A pharmacovigilance analysis published in Diabetes Research and Clinical Practice has also flagged both drugs specifically, finding that semaglutide and tirzepatide showed a notably stronger association with reported muscle atrophy than older GLP-1 medicines in the same class.
How Much Muscle Loss Should Ozempic Users Actually Worry About?
Not everyone on Ozempic loses muscle at the same rate. Age, baseline muscle mass, protein intake, and physical activity all play a role. This matters more for Indians than global averages suggest. A study published in Clinical Diabetes and Endocrinology on Indian adults with type 2 diabetes found sarcopenia, the medical term for muscle loss, in 60% of diabetic patients and sarcopenic obesity, where fat and muscle loss coexist, in 40% of that group. Combine a GLP-1 drug with an existing tendency toward low muscle mass, and the risk compounds.
Ozempic vs Mounjaro: Similar Mechanism, Similar Risk
Neither Ozempic nor Mounjaro is designed to target muscle tissue directly, and neither drug's official prescribing information lists muscle wasting as a primary pharmacological effect. The lean mass loss appears to be a side effect of rapid, large-scale weight loss itself rather than something unique to how the drug works. That said, Mounjaro's dual-action mechanism tends to produce faster, larger weight loss than Ozempic, which in practical terms can mean faster muscle loss too if strength training and protein intake aren't part of the plan.
What This Means for Your Joints
The joint story is genuinely two-sided. On one hand, losing weight is one of the most effective non-drug interventions for knee osteoarthritis, since every kilogram lost meaningfully reduces the mechanical load on weight-bearing joints. The STEP 9 trial, published in Osteoarthritis and Cartilage, tested semaglutide specifically in people with obesity and knee osteoarthritis and found significant improvements in both pain scores and physical function compared with placebo, alongside the expected weight loss.
On the other hand, muscles are what stabilise your joints. The quadriceps support your knees, the muscles around your hips and lower back support your spine. If muscle mass declines faster than fat mass, some of the mechanical benefits of weight loss can be offset by reduced joint support, particularly in people who don't stay active during treatment. This is why doctors increasingly recommend pairing GLP-1 therapy with resistance training rather than relying on the drug alone.
Ozempic vs Mounjaro: A Quick Comparison
| Factor | Ozempic (Semaglutide) | Mounjaro (Tirzepatide) |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 and GIP receptor agonist |
| Typical Weight Loss* | Around 5.6% body weight over ~6 months | Around 8.6% body weight over ~6 months |
| Reported Muscle Loss Risk | Elevated; reported in pharmacovigilance data | Elevated; reported in pharmacovigilance data |
| Joint Health Impact | May improve load-related joint pain through sustained weight loss | Likely similar benefit, though direct evidence is more limited |
| Common Side Effects | Nausea, diarrhoea, vomiting, fatigue | Nausea, diarrhoea, vomiting, fatigue; gastrointestinal effects may be more pronounced |
| Best Suited For | Weight management and type 2 diabetes under medical supervision | Weight management and type 2 diabetes when a dual-incretin approach is appropriate |
*Weight-loss figures are based on available real-world data and may vary depending on individual health status, lifestyle, treatment duration, and medical supervision.
Protecting Muscle and Joints While You Lose Weight
None of this means you should avoid these medications if your doctor has recommended one. It means the weight loss phase needs a plan around it, not just the injection itself.
-
Prioritise protein intake through the day, spread across meals rather than concentrated at dinner, which is a common pattern in Indian eating habits.
-
Add resistance training two to three times a week, even bodyweight exercises count, to signal your body to preserve muscle rather than break it down.
-
Support joint comfort during this transition. Many people experience knee or lower back strain as their body composition shifts quickly, and TENS-based are used alongside physiotherapy to ease everyday joint discomfort without medication, though they don't replace strength training.
-
If you're specifically trying to maintain muscle tone during a weight loss phase, EMS-based can complement, not substitute, an active resistance routine.
-
Get periodic checks on strength and mobility, not just the number on the scale, especially if you're over 45 or have a family history of joint problems.
Supporting Core Strength Along the Way
Belly fat reducing device, a drug-free, EMS-powered abdominal belt that stimulates the core muscles through gentle electrical pulses, can be a convenient addition to a broader core-strengthening routine, especially for people juggling desk jobs or limited time for structured workouts, though it won't replace resistance training or reverse muscle loss from the medication itself. A stronger core also plays a supporting role in overall posture and lower back stability, which matters more during rapid weight loss when the body's centre of gravity and muscle support are both shifting. Using it consistently alongside a protein-rich diet and light daily movement gives the abdominal muscles some passive engagement even on days when a full workout isn't possible. It's best viewed as one small piece of a larger routine rather than a fix on its own.
Ozempic and similar drugs are a genuine medical advance, but the goal of treatment should be a healthier body, not just a lighter one. Talk to your doctor or an endocrinologist about a monitoring plan that tracks muscle mass alongside weight, and loop in a physiotherapist if joint discomfort shows up during treatment.
Key Takeaways
-
Both Ozempic and Mounjaro can cause meaningful muscle loss alongside fat loss, with studies suggesting 20 to 40% of total weight lost can be lean tissue.
-
Indians may be at higher baseline risk of sarcopenia and sarcopenic obesity, making muscle preservation especially important during GLP-1 treatment.
-
Mounjaro tends to produce faster, larger weight loss than Ozempic in real-world Indian data, which can mean faster muscle loss without adequate protein and exercise.
-
Weight loss on these drugs can genuinely improve knee osteoarthritis pain, but muscle loss can partly offset that benefit if joints lose their supporting muscle strength.
-
Resistance training, adequate protein, and regular monitoring are essential companions to GLP-1 therapy, not optional extras.
Frequently Asked Questions
Q1.Does Ozempic cause muscle loss in everyone?
Not to the same degree. Muscle loss during Ozempic treatment varies based on age, activity level, and protein intake. People who stay sedentary and eat low protein tend to lose a larger share of lean mass compared to those who stay active during treatment.
Q2.Is Mounjaro worse for muscle loss than Ozempic?
Not necessarily worse by mechanism, but Mounjaro's faster and larger average weight loss can mean a larger absolute amount of muscle loss if resistance training and protein intake aren't part of the routine.
Q3.Can weight loss drugs actually help joint pain?
Yes, particularly for knee osteoarthritis. Clinical research has shown that meaningful weight loss from semaglutide significantly reduces knee pain and improves physical function, largely by reducing mechanical load on the joint.
Q4.How can I tell if I'm losing muscle instead of fat on Ozempic?
Warning signs include feeling weaker during daily tasks, reduced grip strength, or muscles looking softer despite the number on the scale dropping. A body composition scan or a conversation with your doctor can confirm this more reliably than weight alone.
Q5.What's the safest way to lose weight on Ozempic without losing muscle?
Combine the medication with adequate daily protein intake and consistent resistance training. This won't stop all muscle loss, but research suggests it meaningfully reduces the proportion of lean mass lost compared to medication alone.
